NCT04539678
- Conditions
- Bone Marrow Diseases, Cardiovascular Diseases, Diagnosis of Myeloproliferative Neoplasia, +8 more
- Locations
-
- Nantes University Hospital Nantes, Loire-Atlantique, France
Clinical trial condition
Impact of Treatment With Cytoreducing Agent
Explore clinical trials studying Impact of Treatment With Cytoreducing Agent. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies